Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.860 | 0.800 | 10 | 2007 | 2019 | |||||
Rheumatoid Arthritis
|
2387 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.850 | 0.818 | 11 | 2008 | 2019 | |||||
Autoimmune Diseases
|
428 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.810 | 1.000 | 3 | 2010 | 2019 | |||||
Hypothyroidism
|
283 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||
Autoantibody measurement
|
52 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
142 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
132 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
141 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Immune System Diseases
|
116 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Multiple Sclerosis
|
1022 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
CELIAC DISEASE, SUSCEPTIBILITY TO, 3 (finding)
|
1 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 0 | ||||||||
HASHIMOTO THYROIDITIS, SUSCEPTIBILITY TO
|
1 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.700 | 0 | ||||||||
Graves Disease
|
352 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||
Primary biliary cirrhosis
|
667 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.050 | 1.000 | 5 | 2010 | 2017 | |||||
Autoimmune thyroid disease (AITD)
|
54 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.030 | 1.000 | 3 | 2009 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.030 | 0.667 | 3 | 2015 | 2018 | |||||
Asthma
|
1536 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.020 | 1.000 | 2 | 2010 | 2016 | |||||
Myasthenia Gravis
|
93 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.020 | 0.500 | 2 | 2018 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||
Allergic rhinitis (disorder)
|
176 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Ankylosing spondylitis
|
609 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Appendicitis
|
10 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Breast Carcinoma
|
2793 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Childhood Osteosarcoma
|
151 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Chronic kidney disease stage 5
|
194 | 0.623 | 0.720 | 2 | 203874196 | downstream gene variant | G/A | snv | 0.37 | 0.010 | 1.000 | 1 | 2014 | 2014 |